Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and tolerability of the
combination of bevacizumab and Abraxane in the treatment of women with epithelial ovarian
cancer or peritoneal cancer. The study will also evaluate how the patient's quality of life
is during their treatment.